基本信息
views: 37
![](https://originalfileserver.aminer.cn/sys/aminer/icon/show-trajectory.png)
Bio
Dr. Aparasu's primary areas of research interest include outcomes research and pharmacoepidemiology, with particular emphasis on improving the quality of pharmaceutical care in older adults. His research group has focused on evaluating medication safety in older adults as limited safety evidence exists for chronic medications in this vulnerable population. He believes in multidisciplinary educational and research environments to generate and apply evidence to improve clinical practice. His research team includes clinical pharmacists, geriatricians, and data scientists to provide real-world evidence based on novel methodological approaches for causal inference in observational research. He had continuous research funding from Federal and non-Federal funding sources.
Research Interests
Papers共 444 篇Author StatisticsCo-AuthorSimilar Experts
By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Value in Healthno. 6 (2024): S335
Multiple Sclerosis and Related Disorders (2024): 105539-105539
Value in Healthno. 6 (2024): S268
Value in Healthno. 6 (2024): S234
JOURNAL OF THE AMERICAN PHARMACISTS ASSOCIATIONno. 3 (2024): 102062-102062
Value in Healthno. 6 (2024): S179
Javeria Khalid,Rajender R Aparasu
Expert opinion on drug safetypp.1-15, (2024)
Research in social & administrative pharmacy/Research in social and administrative pharmacyno. 4 (2024): e100-e100
Value in Healthno. 6 (2024): S268-S269
Load More
Author Statistics
#Papers: 426
#Citation: 4563
H-Index: 34
G-Index: 59
Sociability: 6
Diversity: 2
Activity: 62
Co-Author
Co-Institution
D-Core
- 合作者
- 学生
- 导师
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn